Clinical Markers Improve With IV Ertapenem for Hidradenitis Suppurativa

WEDNESDAY, Feb. 21, 2024 -- Treatment of hidradenitis suppurativa (HS) with intravenous ertapenem is associated with improvement in clinical and inflammatory markers, according to a study published online Feb. 19 in JAMA Dermatology. Avigdor...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news